Novo Nordisk CEO says weight-loss drug boom has barely begun (NVO:NYSE) - Seeking Alpha

Novo Nordisk CEO says weight-loss drug boom has barely begun (NVO:NYSE)  Seeking AlphaPill vs. shot: Cost and convenience reshape the weight loss drug market  ReutersPharma just ‘scratching the surface’ of weight-loss drug market  Financial TimesWhy Pharma Is Only Beginning to Tap the Weight-Loss Drug Revolution  vocal.mediaObesity Treatment Pipeline Expands with New FDA Updates and Innovations  National Today